Panakeia ("the Company"), the world's first in silico multi-omics company, today unveiled landmark pathway activation data in cancers at the American Association for Cancer Research (AACR) Annual ...

The treatment landscape of generalised myasthenia gravis, a prototypic antibody-mediated disorder of the neuromuscular junction, has considerably evolved in the past 8 years.1 The approval of targeted ...

Accurate measurement of HMGB-1, neopterin and sIL-2R supports reliable assessment of immune activation across clinical and ...

Objective SLE is a systemic autoimmune disease in which the complement system plays a key pathogenic role, yet the ...

Researchers at the National University of Singapore have measured the precise force required to open Piezo1, a protein that ...

First patient dosed in Opti-GAIN, a first-in-human Phase I/II clinical trial of CTx001 in Geographic Atrophy secondary to AMD CTx001 is an investigational AAV-based gene therapy designed to deliver ...

The study also clarifies the functional role of the receptor's conserved sodium-binding pocket, showing that sodium egress strongly promotes activation-related conformational states, including a ...

Valenzuela has received grants and/or research support from Mallinckrodt and Artiva Biotherapeutics; speaker fees from Lilly, Amgen, UCB, Pfizer, Genentech, Novartis ...

To learn more about our editorial approach, explore The Direct Message methodology. Denise, a 38-year-old paralegal in Tampa, doesn’t smoke. She’s never touched a cigarette. She runs three mornings a ...

Backed by Over a Decade of Research, Fullify Represents a New, Biology-Driven Approach in a Category Long Dominated by Short-Term Fixes Created by Biocodex, the makers of Florastor ®, Fullify™ is a ...

Biocodex Introduces Fullify™, a First-of-Its-Kind Precision Probiotic Clinically Shown to Activate the Gut-Brain Pathway to Support Appetite Management Backed by Over a Decade of Research, Fullify ...

Cedars-Sinai investigators have identified a genetic variant that increases people's risk of developing perianal Crohn's disease, the most debilitating manifestation of Crohn's disease. Science X ...